| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.6B | $26.7B | $25.3B | $29.3B | $23.1B | $20.4B | $4.9B | $5.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $7.3B | $7.1B | $5.8B | $5.4B | $3.7B | $4.9B | $0.7B | $0.6B |
| Net Income | $4.3B | $4.3B | $3.8B | $3.4B | $2.3B | $3.1B | $0.4B | $0.3B |
| EPS (Basic) | $3.94 | $4.02 | $3.64 | $3.28 | $2.26 | $2.95 | $0.42 | $0.27 |
| EPS (Diluted) | $3.92 | $3.99 | $3.62 | $3.26 | $2.24 | $2.93 | $0.42 | $0.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $155.7B | $145.2B | $139.3B | $134.9B | $127.5B | $122.9B | $118.7B | $116.9B |
| Current Assets | $10.9B | $10.7B | $10.4B | $10.4B | $9.0B | $8.6B | $9.8B | $9.6B |
| Cash & Equivalents | $1.6B | $1.1B | $0.7B | $1.9B | $1.8B | $1.1B | $2.0B | $1.4B |
| Total Liabilities | $116.9B | $108.5B | $104.1B | $100.4B | $95.0B | $90.4B | $86.7B | $87.6B |
| Current Liabilities | $16.9B | $16.0B | $13.5B | $15.7B | $10.9B | $12.1B | $12.5B | $14.3B |
| Stockholders' Equity | $36.0B | $33.2B | $31.4B | $30.4B | $27.9B | $28.0B | $27.5B | $24.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.8B | $9.8B | $7.6B | $6.3B | $6.2B | $6.7B | $5.8B | $6.9B |
| Investing Cash Flow | $-14.0B | $-9.4B | $-9.7B | $-8.4B | $-7.4B | $-7.0B | $-3.4B | $-5.8B |
| Capital Expenditures | $12.7B | $9.0B | $9.1B | $7.9B | $7.2B | $7.4B | $7.6B | $8.0B |
| Financing Cash Flow | $4.7B | $-0.2B | $1.0B | $2.3B | $1.9B | $-0.6B | $-1.9B | $-1.8B |